BuzBuz Capital Corp. (“BuzBuz”) and Inolife R&D Inc. (“Inolife” or the “Company”) announced that they have entered into a non-binding letter of intent to complete a business combination (the “Transaction”). The letter of intent was negotiated at arm's length and is effective as of August 6, 2020.

Upon conclusion of the Transaction, a board of directors of five individuals is to be established and further details will be announced. At this time, the following 3 individuals will be insiders: Dr. John Leombruno moved into the Pharmaceutical industry and held various roles of increasing responsibility, culminating in the position of Vice President, Medical Affairs. In 2007, Dr. Leombruno co-founded one of the first Specialty Pharmacies in Canada.

The Specialty Pharmacy business grew to include a Patient Support Program division and a pharmaceutical importing and distribution business and was acquired by a multinational corporation. Michael Wright - entrepreneur with over 20 years of experience as an executive. With over 25 years' experience in the financial industry, he has served many commercial industry leaders, both private and publicly listed companies as well as traditional financial and institutional lenders.